Tyrosine kinase inhibitors targeting vascular endothelial growth factor and the risk of aortic dissection—A pharmacovigilance analysis

There are concerns by the United States Food and Drug Administration (FDA) regarding a potential link between tyrosine kinase inhibitors targeting vascular endothelial growth factor (VEGF‐TKIs) and the risk of aortic dissection. Elevation of blood pressure induced by VEGF‐TKIs has been discussed as...

Descripción completa

Detalles Bibliográficos
Autores principales: Dörks, Michael, Jobski, Kathrin, Herget‐Rosenthal, Stefan, Hoffmann, Falk, Douros, Antonios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796803/
https://www.ncbi.nlm.nih.gov/pubmed/33421342
http://dx.doi.org/10.1002/prp2.707

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796803/
https://www.ncbi.nlm.nih.gov/pubmed/33421342
http://dx.doi.org/10.1002/prp2.707

Ejemplares similares